• 1
    Glant TT, Mikecz K, Arzoumanian A, Poole AR. Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology. Arthritis Rheum 1987; 30:201 12.
  • 2
    Glant TT, Cs-Szabó G, Nagase H, Jacobs JJ, Mikecz K. Progressive polyarthritis induced in BALB/c mice by aggrecan from human osteoarthritic cartilage. Arthritis Rheum 1998; 41:1007 18.
  • 3
    Mikecz K, Glant TT, Poole AR. Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum 1987; 30:306 18.
  • 4
    Glant TT, Buzás EI, Finnegan A, Negroiu G, Cs-Szabó G, Mikecz K. Critical role of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation. J Immunol 1998; 160:3812 9.
  • 5
    Mikecz K, Glant TT, Buzás E, Poole AR. Proteoglycan-induced polyarthritis and spondylitis adoptively transferred to naive (nonimmunized) BALB/c mice. Arthritis Rheum 1990; 33:866 76.
  • 6
    Banerjee S, Webber C, Poole AR. The induction of arthritis in mice by the cartilage proteoglycan aggrecan: roles of CD4+ and CD8+ T cells. Cell Immunol 1992; 144:347 57.
  • 7
    Buzás EI, Brennan FR, Mikecz K et al. A proteoglycan (aggrecan)-specific T cell hybridoma induces arthritis in BALB/c mice. J Immunol 1995; 155:2679 87.
  • 8
    Brennan FR, Mikecz K, Buzás EI et al. Antigen-specific B cells present cartilage proteoglycan (aggrecan) to an autoreactive T cell hybridoma derived from a mouse with proteoglycan-induced arthritis. Clin Exp Immunol 1995; 101:414 21.
  • 9
    Mosmann TR, Cherwinski H, Bond MA, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136:2348 57.
  • 10
    Kelso A. Th1 and Th2 subsets: paradigms list? Immunol Today 1995; 16:374 9.
  • 11
    Kiely PD. The Th1-Th2 model—what relevance to inflammatory arthritis? Ann Rheum Dis 1998; 57:328 30.
  • 12
    Doncarli A, Stasiuk LM, Fournier C, Abehsira-Amar O. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis . Eur J Immunol 1997; 27:1451 8.
  • 13
    Glant TT, Mikecz K, Poole AR. Monoclonal antibodies to different protein-related epitopes of human articular cartilage proteoglycans. Biochem J 1986; 234:31 41.
  • 14
    Mikecz K, Brennan FR, Kim JH, Glant TT. Anti-CD44 treatment abrogates tissue edema and leukocyte infiltration in murine arthritis. Nature Med 1995; 1:558 63.
  • 15
    Czerkinsky C, Nilsson LA, Nygren H, Ouchterlony O, Tarkowsky A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods 1983; 65:109 21.
  • 16
    Negroiu G, Roughley PJ, Cs-Szabó G, Brennan FR, Glant TT. Identification of autoimmune/arthritogenic epitopes of cartilage proteoglycans (PGs) using autoreactive antibodies to mouse aggrecan. Arthritis Rheum 1995; 38:S295(Abstr.).
  • 17
    Adorini L, Guery JC, Trembleau S. Manipulation of the Th1/Th2 cell balance: an approach to treat human autoimmune diseases? Autoimmunity 1996; 23:53 68.
  • 18
    Nicholson LB & Kuchroo VK. Manipulation of the Th1/Th2 balance in autoimmune disease. Curr Opin Immunol 1996; 8:837 42.
  • 19
    Yu M, Johnson JM, Tuohy VK. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis. J Neurosci Res 1996; 45:463 70.
  • 20
    Mauri C, Williams RO, Walmsley M, Feldman M. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 1996; 26:1511 8.
  • 21
    De Franco M, Gille-Perramant MF, Mevel JC, Couderc J. T helper subset involvement in two high antibody responder lines of mice (Biozzi mice): HI (susceptible) and HII (resistant) to collagen-induced arthritis. Eur J Immunol 1995; 25:132 6.
  • 22
    Nakajima A, Hirose S, Yagita H, Okumura K. Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice. J Immunol 1997; 158:1466 72.
  • 23
    Ausubel LJ, Krieger JI, Hafler DA. Changes in cytokine secretion induced by altered peptide ligands of myelin basic protein peptide 85–99. J Immunol 1997; 159:2502 12.
  • 24
    Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994; 91:8562 6.
  • 25
    Van Roon JAG, Van Roy JL, Duits A, Lafeber FP, Bijlsma JW. Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4. Ann Rheum Dis 1995; 54:836 40.
  • 26
    Dolhain RJ, Van Der Heiden AN, Tel Haar NT, Breedveld FC, Miltenburg AM. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum 1996; 39:1961 9.
  • 27
    Van Roon JAG, Verhoef CM, Van Roy JL et al. Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease. Ann Rheum Dis 1997; 56:656 60.
  • 28
    Haddad A, Bienvenu J, Miossec P. Increased production of a Th2 cytokine profile by activated whole blood cells from rheumatoid arthritis patients. J Clin Immunol 1998; 18:399 403.
  • 29
    Isomäki P, Luukkainen R, Lassila O, Toivanen P, Punnonen J. Synovial fluid T cells from patients with rheumatoid arthritis are refractory to the T helper type 2 differentiation-inducing effects of interleukin-4. Immunology 1999; 96:358 64.
  • 30
    Jacobs MJM, Van Den Hoek AEM, Van Lent PLEM, Van De Loo FAJ, Van De Putte LBA, Van Den Berg WB. Role of IL-2 and IL-4 in exacerbations of murine antigen-induced arthritis. Immunology 1994; 83:390 6.
  • 31
    Müssener Å, Litton MJ, Lindroos E, Klareskog L. Cytokine production in synovial tissue of mice with collagen-induced arthritis (CIA). Clin Exp Immunol 1997; 107:485 93.
  • 32
    Pearson CI & McDevitt HO. Redirecting Th1 and Th2 responses in autoimmune disease. Curr Opin Microbiol Immunol 1999; 238:79 122.
  • 33
    Van der Graaff WL, Prins APA, Dijkmans BAC, Van Lier RAW. Prognostic value of Th1/Th2 ratio in rheumatoid arthritis. Lancet 1998; 351:1931.
  • 34
    Beech JT, Siew LK, Ghoraishian M, Stasiuk LM, Elson CJ, Thompson SJ. CD4+ Th2 cells specific for mycobacterial 65-kilodalton heat shock protein protect against pristane-induced arthritis. J Immunol 1997; 159:3692 7.
  • 35
    Kageyama Y, Koide Y, Yoshida A et al. Reduced susceptibility to collagen-induced arthritis in mice deficient in IFN-gamma receptor. J Immunol 1998; 161:1542 8.
  • 36
    Kusaba M, Honda J, Fukuda T, Oizumi K. Analysis of type 1 and type 2 T cells in synovial fluid and peripheral blood of patients with rheumatoid arthritis. J Rheumatol 1998; 25:1466 71.
  • 37
    Van der Graaff WL, Prins APA, Niers TMH, Dijkmans BAC, Van Lier RAW. Quantitation of interferon gamma- and interleukin-4-producing T cells in synovial fluid and peripheral blood of arthritis patients. Rheumatology 1999; 38:214 20.